Erythromycin Lactobionate

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

2 Sponsors

13 Countries

Phase III

Phase IV

Phase III: 1 Phase IV: 1

Oversight events:

1 serious breach 1 unexpected event across 1 trial

View oversight register →

Sponsors using this IMP

Hospital Foch 1 Universitair Medisch Centrum Utrecht 1

All trials

2 total

Randomized, Embedded, Multifactorial Adaptive Platform trial for Community-Acquired Pneumonia (REMAP-CAP) Ended

2023-507889-89-00 Phase III 13 countries Universitair Medisch Centrum Utrecht
Impact on gastric emptying measured by antral gastric ultrasound of erythromycin administration in stroke patients with indication for mecha… Ended

2023-508120-35-00 Phase IV 1 country Hospital Foch

Showing 1–2 of 2 trials

← All drugs A–Z